前收市價 | 97.05 |
開市 | 96.80 |
買盤 | 無 x 無 |
賣出價 | 無 x 無 |
今日波幅 | 96.65 - 98.95 |
52 週波幅 | 78.60 - 106.30 |
成交量 | |
平均成交量 | 164,129 |
市值 | 33.6B |
Beta 值 (5 年,每月) | 無 |
市盈率 (最近 12 個月) | 5.38 |
每股盈利 (最近 12 個月) | 18.38 |
業績公佈日 | 2024年9月25日 |
遠期股息及收益率 | 0.46 (0.47%) |
除息日 | 2024年5月30日 |
1 年預測目標價 | 122.40 |
Exor, the investment arm of the Agnelli family, has a growing interest in the healthcare industry, where it has already invested almost 4 billion euros ($4.3 billion), CEO John Elkann said on Thursday. "The increased cost of healthcare services combined with a shortage of medical staff is driving demand for innovative new approaches to tackle global health problems," he said in his annual letter to Exor shareholders. Exor views healthcare as a "long-term, structural growth sector," added Elkann, the scion of the Agnelli family and chair of automakers Stellantis and Ferrari.
Exor, the investment arm of the Agnelli family, has a growing interest in the healthcare industry, where it has already invested almost 4 billion euros ($4.3 billion), CEO John Elkann said on Thursday. "The increased cost of healthcare services combined with a shortage of medical staff is driving demand for innovative new approaches to tackle global health problems," he said in his annual letter to Exor shareholders. Exor views healthcare as a "long-term, structural growth sector," said Elkann, the scion of the Agnelli family and chair of automakers Stellantis and Ferrari.
MILAN (Reuters) -Italy's Agnelli family has a 10.1% stake in New York-listed information services provider Clarivate through their investment arm Exor, the two companies said on Monday, adding that Exor could increase its stake to up to 17.5%. Exor controls companies including Ferrari, agriculture and construction machine maker CNH and Serie A soccer club Juventus JUVE.MI, and is the single largest shareholder in automaker Stellantis. "Exor becomes a long-term investor in Clarivate, endorsing the strategic direction set out by the company's management and board," the companies said.